Join us for the next in the series of our Clinical Trial Special Interest Groups with Afortiori Development at this webinar where we will be discussing research location: where and why!
When it comes to making decisions about your chosen research trial setting, there is much to consider. Join us to learn how to make the right location choice for your product and understand how patient pathways, healthcare setting, institutional policies, geography and costs can affect your trial success.
DURATION: 1 hour
This free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Speaker Profiles:
Charlotte Culver, Clinical Project Leader, Afortiori Development
Charlotte has a strong project management background in clinical research Phases I-V while delivering both commercial and non-commercial research throughout her career to produce quality results.
She is experienced in both pharmaceutical and device trials across several disease areas throughout the lifecycle of the project, in collaboration with key pharmaceutical and device companies in the industry.
Her proven project management track record provides her with the tools to deliver excellence and detailed delivery in clinical, regulatory, and financial aspects of clinical research.
Throughout her research career, she has worked on projects internationally, as either multicentered or single-centre as lead.
James Fry, Head of Life Sciences and Partner at Mills & Reeve
James heads the firm’s fast growing, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech, medical device, diagnostic, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property, commercial contracting and regulatory work.